Different roles of GNAS and cAMP signaling during early and late stages of osteogenic differentiation

Hormone and Metabolic Research

Volumn 44, Issue 10, 2012, Pages 724-731

  Zhang, S ^a   Kaplan, F S ^a,b   Shore, E M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

BMP; FD; fibrous dysplasia; POH; progressive osseous heteroplasia; SMAD

Indexed keywords

2',5' DIDEOXYADENOSINE; BONE MORPHOGENETIC PROTEIN; CYCLIC AMP; FORSKOLIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMAD PROTEIN;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GNAS GENE; MOUSE; NONHUMAN; OSTEOBLAST; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; UPREGULATION;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINEAGE; CYCLIC AMP; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; MICE; OSTEOBLASTS; OSTEOGENESIS; PPAR GAMMA; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 84866083087     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1321845     Document Type: Article

References (62)

1. Shore E M, Ahn J, Jan de Beur S, Li M, Xu M, Gardner R J, Zasloff M A, Whyte M P, Levine M A, Kaplan F S. Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N Engl J Med: 2002; 346 99 106
2. Shore E M, Kaplan F S. Inherited human diseases of heterotopic bone formation. Nat Rev Rheumatol: 2010; 6 518 527
3. Kaplan F S, Shore E M. Progressive osseous heteroplasia. J Bone Miner Res: 2000; 15 2084 2094
4. Dumitrescu C E, Collins M T. McCune-Albright syndrome. Orphanet J Rare Dis: 2008; 3 12
5. Riminucci M, Robey P G, Saggio I, Bianco P. Skeletal progenitors and the GNAS gene: fibrous dysplasia of bone read through stem cells. J Mol Endocrinol: 2010; 45 355 364
6. Weinstein L S, Liu J, Sakamoto A, Xie T, Chen M. Minireview: GNAS: normal and abnormal functions. Endocrinology: 2004; 145 5459 5464
7. Weinstein L S, Chen M, Xie T, Liu J. Genetic diseases associated with heterotrimeric G proteins. Trends Pharmacol Sci: 2006; 27 260 266
8. Aydin C, Aytan N, Mahon M J, Tawfeek H A, Kowall N W, Dedeoglu A, Bastepe M. Extralarge XL(alpha)s (XXL(alpha)s), a variant of stimulatory G protein alpha-subunit (Gs(alpha)), is a distinct, membrane-anchored GNAS product that can mimic Gs(alpha). Endocrinology: 2009; 150 3567 3575
9. Bastepe M. The GNAS Locus: Quintessential Complex Gene Encoding Gsalpha, XLalphas, and other Imprinted Transcripts. Curr Genomics: 2007; 8 398 414
10. Bastepe M, Gunes Y, Perez-Villamil B, Hunzelman J, Weinstein L S, Juppner H. Receptor-mediated adenylyl cyclase activation through XLalpha(s), the extra-large variant of the stimulatory G protein alpha-subunit. Mol Endocrinol: 2002; 16 1912 1919
11. Plagge A, Gordon E, Dean W, Boiani R, Cinti S, Peters J, Kelsey G. The imprinted signaling protein XL alpha s is required for postnatal adaptation to feeding. Nat Genet: 2004; 36 818 826
12. Spiegel A M, Weinstein L S. Inherited diseases involving g proteins and g protein-coupled receptors. Annu Rev Med: 2004; 55 27 39
13. Kronenberg H M. Gs signaling in osteoblasts and hematopoietic stem cells. Ann NY Acad Sci 1192 327 329
14. Bowler W B, Gallagher J A, Bilbe G. G-protein coupled receptors in bone. Front Biosci: 1998; 3 d769 d780
15. Wang K, Wong Y H. G protein signaling controls the differentiation of multiple cell lineages. Biofactors: 2009; 35 232 238
16. Hong S H, Lu X, Nanes M S, Mitchell J. Regulation of osterix (Osx, Sp7) and the Osx promoter by parathyroid hormone in osteoblasts. J Mol Endocrinol: 2009; 43 197 207
17. Hollnagel A, Ahrens M, Gross G. Parathyroid hormone enhances early and suppresses late stages of osteogenic and chondrogenic development in a BMP-dependent mesenchymal differentiation system (C3H10T1/2). J Bone Miner Res: 1997; 12 1993 2004
18. Ishizuya T, Yokose S, Hori M, Noda T, Suda T, Yoshiki S, Yamaguchi A. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest: 1997; 99 2961 2970
19. Isogai Y, Akatsu T, Ishizuya T, Yamaguchi A, Hori M, Takahashi N, Suda T. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. J Bone Miner Res: 1996; 11 1384 1393
20. Koh A J, Beecher C A, Rosol T J, McCauley L K. 3,5-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro. Endocrinology: 1999; 140 3154 3162
21. Lanske B, Amling M, Neff L, Guiducci J, Baron R, Kronenberg H M. Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest: 1999; 104 399 407
22. Datta N S, Abou-Samra A B. PTH and PTHrP signaling in osteoblasts. Cell Signal: 2009; 21 1245 1254
23. Ghayor C, Ehrbar M, San Miguel B, Gratz K W, Weber F E. cAMP enhances BMP2-signaling through PKA and MKP1-dependent mechanisms. Biochem Biophys Res Commun: 2009; 381 247 252
24. Ohta Y, Nakagawa K, Imai Y, Katagiri T, Koike T, Takaoka K. Cyclic AMP enhances Smad-mediated BMP signaling through PKA-CREB pathway. J Bone Miner Metab: 2008; 26 478 484
25. Nagata A, Tanaka T, Minezawa A, Poyurovsky M, Mayama T, Suzuki S, Hashimoto N, Yoshida T, Suyama K, Miyata A, Hosokawa H, Nakayama T, Tatsuno I. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells. J Cell Physiol: 2009; 221 75 83
26. Siddappa R, Mulder W, Steeghs I, van de Klundert C, Fernandes H, Liu J, Arends R, van Blitterswijk C, de Boer J. cAMP/PKA signaling inhibits osteogenic differentiation and bone formation in rodent models. Tissue Eng Part A: 2009; 15 2135 2143
27. Sakamoto A, Chen M, Nakamura T, Xie T, Karsenty G, Weinstein L S. Deficiency of the G-protein alpha-subunit G(s)alpha in osteoblasts leads to differential effects on trabecular and cortical bone. J Biol Chem: 2005; 280 21369 21375
28. Yamaguchi A, Komori T, Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev: 2000; 21 393 411
29. Pera M F, Tam P P. Extrinsic regulation of pluripotent stem cells. Nature 465 713 720
30. Yu J, Thomson J A. Pluripotent stem cell lines. Genes Dev: 2008; 22 1987 1997
31. Nishikawa S, Jakt L M, Era T. Embryonic stem-cell culture as a tool for developmental cell biology. Nat Rev Mol Cell Biol: 2007; 8 502 507
32. Duplomb L, Dagouassat M, Jourdon P, Heymann D. Concise review: embryonic stem cells: a new tool to study osteoblast and osteoclast differentiation. Stem Cells: 2007; 25 544 552
33. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder J C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci USA: 1993; 90 8424 8428
34. Kurosawa H. Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells. J Biosci Bioeng: 2007; 103 389 398
35. Dani C, Smith A G, Dessolin S, Leroy P, Staccini L, Villageois P, Darimont C, Ailhaud G. Differentiation of embryonic stem cells into adipocytes in vitro. J Cell Sci: 1997; 110 Pt 11 1279 1285
36. Wardle F C, Papaioannou V E. Teasing out T-box targets in early mesoderm. Curr Opin Genet Dev: 2008; 18 418 425
37. Kelsey G. Imprinting on chromosome 20: tissue-specific imprinting and imprinting mutations in the GNAS locus. Am J Med Genet C Semin Med Genet: 2010; 154C 377 386
38. Nuttall M E, Gimble J M. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol: 2004; 4 290 294
39. Muruganandan S, Roman A A, Sinal C J. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci: 2009; 66 236 253
40. Ichida F, Nishimura R, Hata K, Matsubara T, Ikeda F, Hisada K, Yatani H, Cao X, Komori T, Yamaguchi A, Yoneda T. Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation. J Biol Chem: 2004; 279 34015 34022
41. Ryoo H M, Lee M H, Kim Y J. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene: 2006; 366 51 57
42. Cheng S L, Shao J S, Charlton-Kachigian N, Loewy A P, Towler D A. MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem: 2003; 278 45969 45977
43. Madsen L, Kristiansen K. The importance of dietary modulation of cAMP and insulin signaling in adipose tissue and the development of obesity. Ann NY Acad Sci 1190 1 14
44. Lian J B, Stein G S, Javed A, van Wijnen A J, Stein J L, Montecino M, Hassan M Q, Gaur T, Lengner C J, Young D W. Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord: 2006; 7 1 16
45. Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, Aburatani H, Nishimura R, Yoneda T. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem: 2008; 283 29119 29125
46. Xu M, Kaplan F S, Shore E M. GNAS mRNAs from the Paternally-Inherited allele are Decreased in Progressive Osseous Heteroplasia (POH), a Human Disorder of Ectopic Ossification. J Bone Min Res: 2005; 20 S417
47. Luo J, Zhou W, Zhou X, Li D, Weng J, Yi Z, Cho S G, Li C, Yi T, Wu X, Li X Y, de Crombrugghe B, Hook M, Liu M. Regulation of bone formation and remodeling by G-protein-coupled receptor 48. Development: 2009; 136 2747 2756
48. Zhao Y, Ding S. A high-throughput siRNA library screen identifies osteogenic suppressors in human mesenchymal stem cells. Proc Natl Acad Sci USA: 2007; 104 9673 9678
49. Yamashita A, Takada T, Nemoto K, Yamamoto G, Torii R. Transient suppression of PPARgamma directed ES cells into an osteoblastic lineage. FEBS Lett: 2006; 580 4121 4125
50. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung U I, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest: 2004; 113 846 855
51. Shockley K R, Lazarenko O P, Czernik P J, Rosen C J, Churchill G A, Lecka-Czernik B. PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells. J Cell Biochem: 2009; 106 232 246
52. Weinstein L S, Xie T, Qasem A, Wang J, Chen M. The role of GNAS and other imprinted genes in the development of obesity. Int J Obes (Lond): 2010; 34 6 17
53. Plagge A, Kelsey G, Germain-Lee E L. Physiological functions of the imprinted Gnas locus and its protein variants Galpha(s) and XLalpha(s) in human and mouse. J Endocrinol: 2008; 196 193 214
54. Li H, Fong C, Chen Y, Cai G, Yang M. beta2- and beta3-, but not beta1-adrenergic receptors are involved in osteogenesis of mouse mesenchymal stem cells via cAMP/PKA signaling. Arch Biochem Biophys: 2010; 496 77 83
55. Tintut Y, Parhami F, Bostrom K, Jackson S M, Demer L L. cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification. J Biol Chem: 1998; 273 7547 7553
56. Doorn J, Siddappa R, van Blitterswijk C A, de Boer J. Forskolin enhances in vivo bone formation by human mesenchymal stromal cells. Tissue Eng Part A: 2012; 18 558 567
57. Siddappa R, Martens A, Doorn J, Leusink A, Olivo C, Licht R, van Rijn L, Gaspar C, Fodde R, Janssen F, van Blitterswijk C, de Boer J. cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci U S A: 2008; 105 7281 7286
58. Lo K W, Kan H M, Ashe K M, Laurencin C T. The small molecule PKA-specific cyclic AMP analogue as an inducer of osteoblast-like cells differentiation and mineralization. J Tissue Eng Regen Med: 2012; 6 40 48
59. Hakeda Y, Ikeda E, Kurihara N, Nakatani Y, Maeda N, Kumegawa M. Induction of osteoblastic cell differentiation by forskolin. Stimulation of cyclic AMP production and alkaline phosphatase activity. Biochim Biophys Acta: 1985; 838 49 53
60. Nakao Y, Koike T, Ohta Y, Manaka T, Imai Y, Takaoka K. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3,5-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells. Bone: 2009; 44 872 877
61. Yang D C, Tsay H J, Lin S Y, Chiou S H, Li M J, Chang T J, Hung S C. cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. PLoS One: 2008; 3 e1540
62. Huang H, Song T J, Li X, Hu L, He Q, Liu M, Lane M D, Tang Q Q. BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci U S A: 2009; 106 12670 12675